Aytu BioScience
Suzane Kennedy is an experienced Regulatory Affairs and Quality Assurance leader in the life sciences industry. She has worked over 20 years across pharmaceuticals, dietary supplements, and medical devices. Most recently and prior to joining Aytu BioPharma in June 2018, Suzane was the Director of Quality Assurance with a start-up bioscience company, Armis Biopharma that focused on a combination product coming to market. Suzane started her career as a Quality Control Chemist at Upsher-Smith Laboratories and was promoted quickly into a management role. In order to continue her growth in the life science’s field Suzane moved into the medical device regulatory, including roles with ConMed Corporation and Cochlear Americas. She received a B.S. in Chemistry at Metro State University in Denver, Colorado.
This person is not in the org chart
This person is not in any offices
Aytu BioScience
2 followers
Aytu BioPharma (NASDAQ: AYTU) is a specialty pharmaceutical company with a growing commercial portfolio of prescription therapeutics and consumer health products, including ADHD and pediatrics medications. Their evolution has been driven by strategic in-licensing, acquisition-based transactions and organic product growth. As they continue on this trajectory, they are building a complimentary therapeutic development pipeline that will address significant unmet needs.